UTHR — UNITED THERAPEUTICS Corp
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1082554 ·
Last close
$541.89
Market Cap
$23.24B
52W High
$609.35
52W Low
$409.07
ADV30
742,486
Next earnings
2026-10-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 783,300,000 | 683,800,000 | 330,800,000 | 333,000,000 | 7,220,100,000 | 1,803,200,000 | 819,800,000 |
| Mar 2026 | 781,500,000 | 648,100,000 | 325,800,000 | 274,900,000 | 6,714,200,000 | 1,279,700,000 | 813,100,000 |
| Dec 2025 | 790,200,000 | 686,800,000 | 357,500,000 | 364,300,000 | 7,880,000,000 | 1,557,100,000 | 783,800,000 |
| Sep 2025 | 799,500,000 | 698,600,000 | 389,300,000 | 338,700,000 | 7,351,100,000 | 1,340,100,000 | 760,900,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,685,200,000
Investing CF
$744,500,000
Financing CF
$-2,219,600,000
CapEx
$-597,700,000
Dividends Paid
—
Buybacks
$-2,554,900,000
EPS Diluted TTM
$27.95
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$9,164,800,000
Inventory
$193,800,000
Receivables
$310,300,000
ST Investments
$859,100,000
EBIT TTM
$1,585,000,000
Pretax Income TTM
$1,573,000,000
Interest Exp TTM
$12,000,000
Analysts
13
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,154,500,096
EBITDA
$1,496,199,936
Free Cash Flow
$557,137,472
Enterprise Value
$18,659,092,480
Total Cash
$2,662,299,904
Total Debt
$0
Shares Out
42,890,692
Trailing EPS
$27.89
Book Value
$149.97
ROE
19.3%
ROA
11.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,182,700,000 | 1,517,200,000 | 1,334,700,000 | 7,880,000,000 | 783,800,000 | 7,096,200,000 | 1,561,200,000 |
| Dec 2024 | 2,877,400,000 | 1,448,100,000 | 1,195,100,000 | 7,364,000,000 | 920,000,000 | 6,444,000,000 | 1,327,100,000 |
| Dec 2023 | 2,327,500,000 | 1,184,900,000 | 984,800,000 | 7,167,000,000 | 1,182,200,000 | 5,984,800,000 | 978,000,000 |
| Dec 2022 | 1,936,300,000 | 979,700,000 | 727,300,000 | 6,044,500,000 | 1,247,800,000 | 4,796,700,000 | 802,500,000 |
TTM Snapshot
Revenues TTM
$2,668,700,000
NetIncome TTM
$1,138,200,000
OpCashFlow TTM
$0
Assets (Latest)
$7,880,000,000
Forward EPS
$30.03
Max Pain — expiry 2026-10-16
max pain strike: $370.00 · spot: $541.89 · call oi: 8,327 · put oi: 0
Expected Move to 2026-10-16:
±$33.71
(6.22%) —
implied range
$508.18 –
$575.60
· ATM straddle on $540.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GMAB | GENMAB A/S | $21.94B | $35.67 | — |
| GNMSF | GENMAB A/S | $21.83B | $355.00 | — |
| INSM | INSMED Inc | $24.93B | $114.14 | — |
| RPRX | Royalty Pharma plc | $25.99B | $58.36 | — |
| ROIV | Roivant Sciences Ltd. | $26.42B | $36.57 | — |
News headlines (Yahoo Finance, 1h cache)
Why Is United Therapeutics (UTHR) Stock Rocketing Higher Today
2026-09-30 23:33 · Yahoo
United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia
2026-09-30 23:09 · Yahoo
Sector Update: Healthcare Stocks Fall Late Afternoon
2026-09-30 20:00 · Yahoo
LQDA Stock Eyes Worst Day Ever After Judge Upholds Two UTHR Patent Claims
2026-09-30 19:46 · Yahoo
Liquidia shares crater after court rules for United Therapeutics
2026-09-30 18:23 · Yahoo
United Therapeutics (UTHR): Goldman Says Sell As The Base Business Shrinks, But 2027 Holds Real Catalysts
2026-09-29 01:44 · Yahoo
What United Therapeutics (UTHR)'s Goldman Sell Call Amid Bold Pipeline And Buyback Means For Shareholders
2026-09-27 19:10 · Yahoo
United Therapeutics Maps 14 Launches, Fibrosis Growth and Xenokidney Ambitions
2026-09-25 10:02 · Yahoo
Why United Therapeutics (UTHR) Shares Are Falling Today
2026-09-25 01:12 · Yahoo
Biotech Options Buzz: UTHR, NMRA, EWTX
2026-09-18 15:46 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.